Why is the Bubs (ASX:BUB) share price leaping 7% on Tuesday?

Let's further analyse.

| More on:
Two young girls drinking milkshakes with milk around their mouths.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price is set to finish today's session strongly in the green.

Investors have bid shares in the goat milk infant formula company 7% higher.

By comparison, the broader S&P/ASX200 Index (ASX: XJO) has sunk more than 1.4% today.

So what's been fuelling the Bubs share price?

What's pushing the Bubs share price today?

Bubs has not released any price-sensitive news that could explain today's bullish price action.

As a result, there are a few factors that could be pushing shares in the infant formula company higher.

Firstly, shares in fellow infant formula producer A2 Milk Company Ltd (ASX: A2M) have enjoyed a strong run recently.

As a result, sentiment towards the sector could be parlayed onto the Bubs share price.

Secondly, investors might have had a change in heart towards Bub's recent news of expanding into the US.

Earlier this month the company announced plans to expand into the lucrative North American market.

The company's formula products will be launched on both Walmart Inc's (NYSE: WMT) and Amazon.com, Inc.'s (NASDAQ: AMZN) online stores.

Investors did not react to the news favourably, with the Bub share price sinking more than 9% on the day.

The company had flagged first shipment of products in its results presentation for FY21.  

How did Bub's perform in FY21?

Late last month, shares in Bubs took a tumble following a disappointing full-year report.

The infant formula company posted a huge loss for FY21, with a 24% decline in revenue of $46.8 million.

The dour result was driven by a 44% decline in Australian sales to $20.4 million and a 17.5% decline in China sales to $10.47 million.

Other highlights from the company's full-year report included;

  • Underlying EBITDA loss of $28.5 million
  • Statutory loss after tax of $74.7 million
  • Cash balance of $27.9 million

Part of the company's loss for the full year was attributed to a $44.6 million non-cash impairment relating to the Nulac Foods cash generating unit.

Bubs noted that weaker sales, a $12.6 million inventory write down, and the sale of excess bulk powder attributed to a bloated operating loss.

Snapshot of the Bubs share price

Today has provided a brief reprieve for Bub's shareholders.

Shares in the infant formula company have not had a great year, trading more than 39% lower since the start of 2021.

At the time of writing, the Bubs share price is poised to close today's session more than 5% higher.

The company's shares were up more than 11% earlier, having hit an intra-day high of 38 cents.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor Nikhil Gangaram owns shares of A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended A2 Milk, Amazon, and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Thursday for ASX investors.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why BHP, DroneShield, Lotus Resources, and Nuix shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day for the ASX.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why 4DMedical, Dateline, Predictive Discovery, and Wildcat shares are racing higher

These shares are having a good session on hump day. But why?

Read more »